2023 - Research.com Medicine in Denmark Leader Award
Internal medicine, Endocrinology, Insulin, Growth hormone secretion and Hormone are his primary areas of study. Acromegaly, Growth hormone deficiency, Insulin resistance, Ghrelin and Blood plasma are subfields of Internal medicine in which his conducts study. Bone remodeling is closely connected to Chemotherapy in his research, which is encompassed under the umbrella topic of Endocrinology.
His work on Glucose uptake, Pancreatic hormone and Glucagon as part of general Insulin research is frequently linked to Lipid oxidation, thereby connecting diverse disciplines of science. The concepts of his Growth hormone secretion study are interwoven with issues in Blood sampling, VO2 max and Circadian rhythm. His Hormone study combines topics from a wide range of disciplines, such as Treatment Schedule and Short stature.
His scientific interests lie mostly in Internal medicine, Endocrinology, Insulin, Insulin resistance and Growth hormone. His work often combines Internal medicine and Context studies. His study in Lipolysis, Hormone, Adipose tissue, Growth hormone secretion and Growth hormone deficiency is carried out as part of his studies in Endocrinology.
His work on Acipimox as part of general Lipolysis study is frequently linked to Crossover study, therefore connecting diverse disciplines of science. His study in the field of Pancreatic hormone, Glucagon, Glucose uptake and Glucose clamp technique is also linked to topics like Lipid oxidation. His Insulin resistance study incorporates themes from Carbohydrate metabolism and Lipid metabolism.
Jens Otto Lunde Jørgensen mainly investigates Internal medicine, Endocrinology, Insulin resistance, Lipolysis and Acromegaly. His Acipimox, Metabolism, Cohort study, Hormone and Growth hormone investigations are all subjects of Internal medicine research. In the field of Endocrinology, his study on Adipose tissue, Insulin and Skeletal muscle overlaps with subjects such as Crossover study and Context.
His research integrates issues of Glucose uptake and C-reactive protein in his study of Insulin resistance. His biological study deals with issues like Basal, which deal with fields such as Respiratory system and Type 2 Diabetes Mellitus. His Acromegaly research includes elements of Diabetes mellitus, Prospective cohort study, Somatostatin Analogue and Quality of life.
His primary scientific interests are in Internal medicine, Endocrinology, Insulin resistance, Lipolysis and Adipose tissue. In his study, Disease activity is inextricably linked to Diabetes mellitus, which falls within the broad field of Internal medicine. Jens Otto Lunde Jørgensen integrates Endocrinology with Context in his research.
His Insulin resistance research includes themes of Lipid metabolism, Carbohydrate metabolism and Metabolism. His study in Lipolysis is interdisciplinary in nature, drawing from both Transgene, Receptor, Messenger RNA, Intracellular and MAPK/ERK pathway. The study incorporates disciplines such as Fructosamine, Cholesterol, Lipoprotein, Glucose homeostasis and C-reactive protein in addition to Adipose tissue.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
J O Jørgensen;S A Pedersen;L Thuesen;J Jørgensen.
The Lancet (1989)
Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.
Niels Møller;Jens Otto Lunde Jørgensen.
Endocrine Reviews (2009)
Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the growth hormone research society workshop on adult growth hormone deficiency
A. Attanasio;K. Attie;R. Baxter;B. A. Bengtsson.
The Journal of Clinical Endocrinology and Metabolism (1998)
Incidence and late prognosis of cushing's syndrome: a population-based study.
J. Lindholm;S. Juul;J. O. L. Jørgensen;J. Astrup.
The Journal of Clinical Endocrinology and Metabolism (2001)
Weight loss increases circulating levels of ghrelin in human obesity.
Troels Krarup Hansen;Rolf Dall;Hiroshi Hosoda;Masayasu Kojima.
Clinical Endocrinology (2002)
High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten Møller Poulsen;Poul F. Vestergaard;Berthil Frederik Forrest Clasen;Yulia Radko.
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
Olaf M. Dekkers;Erzsébet Horváth-Puhó;Jens Otto L. Jørgensen;Suzanne C. Cannegieter.
The Journal of Clinical Endocrinology and Metabolism (2013)
Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
Jennifer D. Wallace;Ross C. Cuneo;Robert Baxter;Hans Ørskov.
The Journal of Clinical Endocrinology and Metabolism (1999)
Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Sigrun A. Johannesdottir;Erzsébet Horváth-Puhó;Olaf M. Dekkers;Suzanne C. Cannegieter.
JAMA Internal Medicine (2013)
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Thomas Svava Nielsen;Niels Jessen;Jens Otto Lunde Jørgensen;Niels Møller.
Journal of Molecular Endocrinology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: